Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Thrombocythemia, Essential 1Recurrence 1Polycythemia Vera 1Polycythemia 1Ovarian Neoplasms 1Neuroectodermal Tumors 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Dexamethasone 3isatuximab 2Lenalidomide 2Cyclophosphamide 2pomalidomide 1fludarabine phosphate 1fludarabine 1daratumumab 1Watchful Waiting 1Vorinostat 1Vincristine 1Specimen Handling 1Rituximab 1Ranitidine 1R-CHOP protocol 1Prednisone 1Interviews as Topic 1Injections 1Histone Deacetylase Inhibitors 1Filgrastim 1Exercise 1Doxorubicin 1Diphenhydramine 1Data Collection 1Bortezomib 1Acetaminophen 1AC protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hematologic Diseases × Vorinostat × Clear all
NCT00866762 2011-12-12

A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Copenhagen University Hospital at Herlev

Phase 2 Unknown
60 enrolled
Myeloid

Hematologic Diseases, Polycythemia, Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon âš¡